Skip to main content
. 2023 Feb 12;12(8):9351–9362. doi: 10.1002/cam4.5692

FIGURE 1.

FIGURE 1

FLOW DIAGRAM. Diagram shows flow of patients from enrollment to completion of endpoints. 143 men with clinically significant prostate cancer (csPCa) were enrolled. csPCa is defined as GG1 >6 mm (N = 5) or any amount of PCa >GG2 (N = 138). Success is defined as absence of any csPCa on MRI‐guided biopsy. Small amounts of GG1 (<6 mm) were regarded as incidental findings and not considered herein. Among the 25 patients with csPCa at 18 months, 10 are continuing active surveillance (GG2), 5 underwent radical prostatectomy, 3 had radiation therapy, and 7 are undergoing repeat ablation therapy.